To sum up, KP hyperactivity is thought to promote tumoral persistence by skewing the KP away from the neuroprotective branches of the pathway, increasing the tumor’s ability to produce NAD+ to support cellular metabolism and proliferation, and mediating brain tumor immune evasion and resistance to therapies. Here, NPPA is linked to brain neoplasm.